SLE (Systemic Lupus)
Immunology·MeSH: Autoimmune Diseases
Prevalence
30.0 / 100K
1 drug in development·1 company·5 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| CTX112 | CRISPR Therapeutics AG (CRSP) |
Frequently asked questions
How many drugs are in development for SLE (Systemic Lupus)?
BioSniper tracks 1 drug in development for SLE (Systemic Lupus) across 1 company.
How many clinical trials target SLE (Systemic Lupus)?
There are 5 clinical trials targeting SLE (Systemic Lupus) tracked by BioSniper.
What is the prevalence of SLE (Systemic Lupus)?
The estimated prevalence of SLE (Systemic Lupus) is approximately 30.0 per 100,000 population.
Deep-dive into SLE (Systemic Lupus)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis